MARÍA DE LA ALMUDENA
GÓMEZ HERNÁNDEZ
Profesora titular de universidad
José Luis
Martín Ventura
José Luis Martín Ventura-rekin lankidetzan egindako argitalpenak (15)
2024
-
Potential protective role of let-7d-5p in atherosclerosis progression reducing the inflammatory pathway regulated by NF-κB and vascular smooth muscle cells proliferation
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 7
2022
-
Implication of miR-155-5p and miR-143-3p in the Vascular Insulin Resistance and Instability of Human and Experimental Atherosclerotic Plaque
International journal of molecular sciences, Vol. 23, Núm. 18
2018
-
Potential role of insulin receptor isoforms and IGF receptors in plaque instability of human and experimental atherosclerosis
Cardiovascular Diabetology, Vol. 17, Núm. 1
2016
-
Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis
Cardiovascular Diabetology, Vol. 15, Núm. 1
2009
-
Leukotriene B4 enhances the activity of nuclear factor-κB pathway through BLT1 and BLT2 receptors in atherosclerosis
Cardiovascular Research, Vol. 81, Núm. 1, pp. 216-225
2008
-
Effect of Intensive Atorvastatin Therapy on Prostaglandin E2 Levels and Metalloproteinase-9 Activity in the Plasma of Patients With Non-ST-Elevation Acute Coronary Syndrome††Conflicts of interest: Drs. Egido and Tuñón have participated on advisory boards and have been invited speakers for Pfizer.
American Journal of Cardiology, Vol. 102, Núm. 1, pp. 12-18
2006
-
Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: Potential implications for plaque stabilization
Journal of Cardiovascular Pharmacology, Vol. 47, Núm. 1, pp. 60-69
-
El tratamiento con dosis altas de atorvastatina disminuye la inflamación en la aterosclerosis carotídea humana
Clínica e investigación en arteriosclerosis, Vol. 18, Núm. 1, pp. 18-23
-
Overexpression of COX-2, Prostaglandin E Synthase-1 and Prostaglandin E Receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: Regulation by nuclear factor-κB
Atherosclerosis, Vol. 187, Núm. 1, pp. 139-149
2005
-
HMG-CoA reductase inhibitors reduce IκB kinase activity induced by oxidative stress in monocytes and vascular smooth muscle cells
Journal of Cardiovascular Pharmacology, Vol. 45, Núm. 5, pp. 468-475
-
Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month
Stroke, Vol. 36, Núm. 8, pp. 1796-1800
2004
-
Estatinas, inflamación y lesión aterosclerótica
Nefrologia, Vol. 24, Núm. SUPPL.4, pp. 17-20
-
NF-κB Activation and Fas Ligand Overexpression in Blood and Plaques of Patients with Carotid Atherosclerosis: Potential Implication in Plaque Instability
Stroke, Vol. 35, Núm. 2, pp. 458-463
-
Propiedades anti-inflamatorias e inmunomoduladoras de las estatinas
Nefrologia, Vol. 24, Núm. SUPPL.1, pp. 48-49
2002
-
Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells
Atherosclerosis, Vol. 160, Núm. 1, pp. 49-58